 |
Targeting the Toughest DiseasesAuthor: Vertex Pharmaceuticals
Targeting the Toughest Diseases looks at some of humanitys most challenging diseases and how Vertex Pharmaceuticals, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. Language: en Genres: Life Sciences, Natural Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it Trailer: |
Listen Now...
Targeting IgA Nephropathy
Episode 7
Monday, 3 November, 2025
Rachel Benton is a loving mother to an adorable 2-year-old boy named Stetson. Stetson doesn’t know it, but he may have already saved his mom’s life. A routine medical checkup, that Rachel only had because she was pregnant, showed protein in her urine. That discovery led to a biopsy and ultimately a diagnosis of IgA nephropathy – a serious kidney disease.With patients like Rachel in mind, the research team at Vertex Pharmaceuticals is working on new approaches to address IgA nephropathy.Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.-----------------------Featured guests:Rachel Benton is a young mother who lives with IgA nephropathy.Dr. Jonathan Barratt leads the Renal Research Group within the College of Life Sciences, University of Leicester.Mark Bunnage is Executive Vice President and Chief Scientific Officer at Vertex Pharmaceuticals.Dr Manish Maski is a board-certified nephrologist and helps lead Vertex’s research into IgA nephropathy in Boston.Read more about Vertex's commitment to targeting kidney disease
